Genomics
and proteomics are crucial in drug discovery and development, as they study
the structure and function of genomes, particularly genes. The impact of
genomics and pharmacogenomics on clinical medicine includes treatment
interventions in cardiovascular medicine, endocrinology, and oncology.
Proteomics techniques have been used to characterize rapid post-translational
protein modifications in highly complex molecular signatures as important
disease-related biomarkers from experimental model systems or clinical
samples.
Genomics
and proteomics are crucial in drug discovery and development, as they study
the structure and function of genomes, particularly genes. The impact of
genomics and pharmacogenomics on clinical medicine includes treatment
interventions in cardiovascular medicine, endocrinology, and oncology.
Proteomics techniques have been used to characterize rapid post-translational
protein modifications in highly complex molecular signatures as important
disease-related biomarkers from experimental model systems or clinical
samples.
